Literature DB >> 12471351

[Retinal vein occlusion and carotid Doppler imaging].

D Sayag1, A Gotzamanis, C Brugniart, A Segal, A Ducasse, V Chambre, A Glacet-Bernard.   

Abstract

PURPOSE: To investigate retinal vein occlusion with B-mode ultrasonography carotid and color Doppler imaging.
METHODS: In 223 patients (225 eyes) presenting with retinal vein occlusion, we retrospectively investigated vascular risk factors (hypertension, diabetes, hyperlipidemia, cardiovascular history, smoking, and glaucoma), standard laboratory tests, and color Doppler imaging of the carotid artery.
RESULTS: The data from 106 women (47.54%) and 117 men (52.46%), with a mean age of 65 years, were studied, with 169 patients presenting a central retinal vein occlusion (CRVO) and 56 a branch retinal vein occlusion (BRVO). Thirteen patients (6%) had significant carotid artery stenosis (>=70%), which was the single etiology. Forty patients (18%) had nonsignificant carotid artery stenosis (<70%) with a risk of embolism production. Such carotid artery lesions found in color Doppler imaging in the RVO investigations were significantly more frequent in older patients (>65 years) who presented at least two RVO risk factors (p<0.001).
CONCLUSION: This study has shown the the advantages of carotid Doppler imaging in retinal vein occlusion.

Entities:  

Mesh:

Year:  2002        PMID: 12471351

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  2 in total

1.  The predictive value of retinal vascular findings for carotid artery atherosclerosis: are further recommendations with regard to carotid atherosclerosis screening needed?

Authors:  Yeo-Jeong Song; Kyoung-Im Cho; Seong-Man Kim; Hyun-Duk Jang; Jung-Min Park; Sang-Soo Kim; Dong-Jun Kim; Hyeon-Gook Lee; Tae-Ik Kim
Journal:  Heart Vessels       Date:  2012-06-09       Impact factor: 2.037

2.  Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis.

Authors:  Ning Cheung; Ronald Klein; Jie Jin Wang; Mary Frances Cotch; Amirul F M Islam; Barbara E K Klein; Mary Cushman; Tien Yin Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-06       Impact factor: 4.799

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.